Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 9,599,852
- Total 13F shares
- 20,347,324
- Share change
- +10,836,086
- Total reported value
- $265,987,000
- Price per share
- $13.08
- Number of holders
- 50
- Value change
- +$141,427,052
- Number of buys
- 36
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 007002108:
Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
70%
|
6,708,507
|
$94,255,000 | — | 31 Dec 2020 | |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
|
Company |
6.9%
|
662,676
|
$9,311,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
364,141
|
$5,115,000 | — | 31 Dec 2020 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
3.6%
|
344,011
|
$4,833,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
274,462
|
$3,856,000 | — | 31 Dec 2020 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.9%
|
181,626
|
$2,552,000 | — | 31 Dec 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.8%
|
174,277
|
$2,449,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
1.3%
|
129,335
|
$1,817,000 | — | 31 Dec 2020 | |
| J. Goldman & Co LP |
13F
|
Company |
1.1%
|
101,240
|
$1,422,000 | — | 31 Dec 2020 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.81%
|
77,577
|
$1,090,000 | — | 31 Dec 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.49%
|
47,421
|
$666,000 | — | 31 Dec 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.47%
|
44,931
|
$632,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.45%
|
42,846
|
$602,000 | — | 31 Dec 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.39%
|
37,915
|
$533,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
33,476
|
$470,000 | — | 31 Dec 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.31%
|
29,981
|
$421,000 | — | 31 Dec 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.29%
|
27,497
|
$386,000 | — | 31 Dec 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.28%
|
27,208
|
$382,000 | — | 31 Dec 2020 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.27%
|
25,744
|
$362,000 | — | 31 Dec 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
25,275
|
$355,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.26%
|
24,985
|
$351,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.26%
|
24,517
|
$344,000 | — | 31 Dec 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
24,284
|
$341,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
22,078
|
$310,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
15,790
|
$222,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
15,466
|
$217,000 | — | 31 Dec 2020 | |
| Golden State Equity Partners |
13F
|
Company |
0.14%
|
13,145
|
$184,000 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
11,585
|
$163,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
10,240
|
$144,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.1%
|
9,289
|
$130,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
933
|
$13,000 | — | 31 Dec 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
914
|
$13,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
748
|
$11,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
574
|
$8,000 | — | 31 Dec 2020 | |
| Penserra Capital Management LLC |
13F
|
Company |
0%
|
450
|
$6,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
446
|
$6,000 | — | 31 Dec 2020 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
400
|
$6,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
381
|
$5,000 | — | 31 Dec 2020 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
142
|
$2,000 | — | 31 Dec 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
59
|
$1,000 | — | 31 Dec 2020 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0%
|
50
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q1 2021
As of 31 Mar 2021,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,347,324 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Avidity Partners Management LP, Abingworth LLP, Consonance Capital Management LP, Point72 Asset Management, L.P., VR Adviser, LLC, VANGUARD GROUP INC, Johnson & Johnson Innovation - JJDC, Inc., BlackRock Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
39
Q1 2021 holders
50
Holder diff
11
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.